{
    "Trade/Device Name(s)": [
        "Healgen MDMA (Ecstasy) Test (Strip, Cassette, Cup, Dip Card)",
        "Healgen Phencyclidine Test (Strip, Cassette, Cup, Dip Card)"
    ],
    "Submitter Information": "HEALGEN SCIENTIFIC LLC",
    "510(k) Number": "K150096",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052115"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LAF",
        "LCM"
    ],
    "Summary Letter Date": "January 12, 2015",
    "Summary Letter Received Date": "January 20, 2015",
    "Submission Date": "February 26, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.3610"
    ],
    "Regulation Name(s)": [
        "Methamphetamine test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Methylenedioxymethamphetamine",
        "Phencyclidine"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow chromatographic immunoassay"
    ],
    "Methodologies": [
        "Competitive binding",
        "Antigen-antibody immunochemistry",
        "Lateral flow"
    ],
    "Submission Type(s)": [
        "Strip",
        "Cassette",
        "Dip Card",
        "Cup"
    ],
    "Document Summary": "FDA 510(k) summary for Healgen MDMA (Ecstasy) and Phencyclidine Tests for qualitative detection of drugs of abuse in urine using immunochromatographic lateral flow assays",
    "Indications for Use Summary": "Qualitative detection of methylenedioxymethamphetamine (MDMA, Ecstasy) at 500 ng/mL and phencyclidine at 25 ng/mL in human urine for prescription and over-the-counter in vitro diagnostic use",
    "fda_folder": "Toxicology"
}